Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?


OverviewForecastRevenueFinancialsChart

Stoke Therapeutics Ownership Summary


Stoke Therapeutics is owned by 26.53% institutional investors, 4.19% insiders, and 69.28% retail investors. Fmr is the largest institutional shareholder, holding 11.76% of STOK shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.

STOK Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockStoke Therapeutics26.53%4.19%69.28%
SectorHealthcare Stocks 42.54%10.83%46.63%
IndustryBiotech Stocks 45.22%10.75%44.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr6.87M11.76%$161.33M
Blackrock5.41M11.70%$73.08M
Blackrock funding, inc. /de5.99M10.26%$140.70M
Lynx1 capital management lp5.40M9.26%$109.88M
Rtw investments, lp5.12M8.78%$120.40M
Baker bros. advisors lp4.63M7.94%$108.90M
Cowen and company3.37M7.28%$45.47M
Redmile group4.18M7.16%$98.13M
Morgan stanley3.54M6.06%$83.12M
Toronto dominion bank3.17M5.44%$74.57M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Skorpios trust2.26M99.68%$53.02M
Lynx1 capital management lp5.40M22.37%$109.88M
Redmile group4.18M9.55%$98.13M
Birchview capital, lp210.00K3.73%$4.93M
Bioimpact capital789.70K3.04%$18.56M
Opaleye management682.02K2.27%$16.03M
Siren2.25M2.07%$52.81M
Checkpoint capital212.05K1.67%$4.98M
Bvf inc/il1.66M1.58%$38.94M
Rtw investments, lp5.12M1.48%$120.40M

Top Buyers

HolderShares% AssetsChange
Bvf inc/il1.66M1.58%1.66M
Blackrock5.41M0.00%1.55M
Point72 asset management1.31M0.05%1.31M
Royal bank of canada915.79K0.00%771.72K
Wellington management group llp737.75K0.00%600.69K

Top Sellers

HolderShares% AssetsChange
Marshall wace, llp768.29K0.02%-1.53M
Healthcare of ontario pension plan trust fund---1.39M
Logos global management lp---1.05M
Skorpios trust2.26M99.68%-1.00M
Ci private wealth---659.83K

New Positions

HolderShares% AssetsChangeValue
Bvf inc/il1.66M1.58%1.66M$38.94M
Point72 asset management1.31M0.05%1.31M$30.71M
Norges bank314.80K0.00%314.80K$3.47M
Rhenman & partners asset management ab250.00K0.65%250.00K$5.88B
Parkman healthcare partners250.00K0.61%250.00K$5.88M

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-5.00
Ifp advisors-6.00
Mid-american wealth advisory group-17.00
Parallel advisors-24.00
Lindbrook capital-30.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 202564-49.61%15,482,785-74.37%260.25%38-47.95%16-44.83%
Jun 30, 20251334.72%65,529,80716.03%1121.18%732.82%3322.22%
Mar 31, 2025128-2.29%63,381,9189.17%1091.03%704.48%28-33.33%
Dec 31, 202438-68.33%19,005,198-67.36%330.32%20-67.21%10-72.22%
Sep 30, 20241203.45%58,218,197-5.03%1030.59%61-25.61%3663.64%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.61M2.97%-
Fidelity Select Biotechnology1.57M2.86%330.59K
Vanguard Total Stock Mkt Idx Inv1.54M2.81%-34.18K
Polar Capital Biotech S Inc1.25M2.28%366.35K
Fidelity Select Health Care1.20M2.19%200.00K
iShares Russell 2000 ETF992.23K1.81%-
Fidelity Stock Selector Small Cap972.10K1.77%-
FIAM Small Cap Core CIT Cl B871.00K1.59%871.00K
BlackRock Health Sciences Opps Inv A857.19K1.56%-68.75K
BGF World Healthscience A2 USD851.11K1.56%-

Recent Insider Transactions


DateNameRoleActivityValue
Dec 08, 2025Allan Jonathan GENERAL COUNSEL & CORP SECSell$87.34K
Dec 08, 2025Allan Jonathan GENERAL COUNSEL & CORP SECSell$41.07K
Dec 08, 2025Kaye Edward M. MD-Sell$269.07K
Dec 08, 2025Kaye Edward M. MD-Sell$120.25K
Dec 08, 2025Kaye Edward M. MD-Sell$44.06K

Insider Transactions Trends


DateBuySell
2025 Q4-42
2025 Q3-13
2025 Q2-5
2025 Q1-6
2024 Q4-11

STOK Ownership FAQ


Who Owns Stoke Therapeutics?

Stoke Therapeutics shareholders are primarily institutional investors at 26.53%, followed by 4.19% insiders and 69.28% retail investors. The average institutional ownership in Stoke Therapeutics's industry, Biotech Stocks , is 45.22%, which Stoke Therapeutics falls below.

Who owns the most shares of Stoke Therapeutics?

Stoke Therapeutics’s largest shareholders are Fmr (6.87M shares, 11.76%), Blackrock (5.41M shares, 11.70%), and Blackrock funding, inc. /de (5.99M shares, 10.26%). Together, they hold 33.72% of Stoke Therapeutics’s total shares outstanding.

Does Blackrock own Stoke Therapeutics?

Yes, BlackRock owns 11.70% of Stoke Therapeutics, totaling 5.41M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 73.08M$. In the last quarter, BlackRock increased its holdings by 1.55M shares, a 40.19% change.

Who is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested?

Skorpios trust is Stoke Therapeutics’s biggest shareholder by percentage of total assets invested, with 99.68% of its assets in 2.26M Stoke Therapeutics shares, valued at 53.02M$.

Who is the top mutual fund holder of Stoke Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Stoke Therapeutics shares, with 2.97% of its total shares outstanding invested in 1.61M Stoke Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools